Product Profile

Xiangke
  • Specification
    50mg
  • Therapeutic field
    Hematological neoplasms
  • Dosage form
    Tablets
  • Approval number
    SFDA approval number H20052083
  • Executive standard
    YBH08032009
Return

Investor Relations

Career Development

Address: No.866, Mogan Mountain Road, Hangzhou

Phone: +86-571-89903388

Huadong Medicine Co.,Ltd © 2018 All Rights Reserved